MMP-2, which mediates the degradation of the extracellular matrix (ECM), is known to be is one of the most important enzymes that is considered to facilitate tumor invasion in a series of invasive breast carcinomas, which is overexpressed in a variety of malignant tissues compared to normal tissues, such as cancers of the breast, colon, stomach and lung. Here, MMP2 is linked to neoplasm.